Skip to main navigation
Skip to search
Skip to main content
Fox Chase Cancer Center Home
Help & FAQ
Home
Profiles
Research Units
Research Resources
Research Outputs
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
A new strategy to ERADicate HER2-positive breast tumors?
Sanjeevani Arora
,
Erica A. Golemis
Cancer Epigenetics Institute
Cancer Prevention and Control (CPC)
Cancer Research Training and Education
Cancer Signaling and Microenvironment (CSM)
Greenberg Pancreatic Cancer Institute
Research output
:
Contribution to journal
›
Article
›
peer-review
3
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'A new strategy to ERADicate HER2-positive breast tumors?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Neuroscience
Trastuzumab
100%
Endoplasmic reticulum
50%
Medicine and Dentistry
Endoplasmic Reticulum Associated Degradation
50%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
50%